Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2025-12-24 @ 11:48 AM
NCT ID:
NCT06250361
Brief Summary:
The goal of this observational study is to determine the factors associated with a delayed diagnosis and/or an immediately complicated disease for CD patients.
A questionnaire will be completed by the patients, each questionnaire has a patient section and a physician section.
Detailed Description:
Number of patients expected : at least 600, coming from all types of practices (ANGH (expert hospitals), GETAID (expert university hospitals) and CREGG (expert private practice)).
Recruitment period : 1 year
Primary endpoint : The primary endpoint is the description of the factors linked to:
* The IBD
* The patient (see patient questionnaire in annex 1)
* The health care system
* The patient's self-care
Secondary endpoint :
* Validation of the "red flags" in a prospective cohort.
* Comparison with the EPIMAD population, especially the location and severity.
Study:
NCT06250361
Study Brief:
Protocol Section:
NCT06250361